DENVER, Nov. 11, 2022 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a supplier of intraoperative neuromonitoring (“IONM”) and distant neurology providers, introduced at present that shareholders of document as of the shut of business on November 18, 2022, will likely be entitled to note of, and to vote at, the Annual Meeting of Shareholders to be held on December 28, 2022. The Company anticipates that the discover of the Annual Meeting of Shareholders will likely be mailed to shareholders on or about November 28, 2022.
About Assure Holdings
Assure Holdings Corp. is a best-in-class supplier of outsourced intraoperative neuromonitoring and distant neurology providers. The Company delivers a turnkey suite of medical and operational providers to help surgeons and medical amenities throughout invasive procedures that place the nervous system in danger together with neurosurgery, backbone, cardiovascular, orthopedic and ear, nostril and throat surgical procedures. Assure employs extremely skilled technologists that present a direct level of contact within the working room. Physicians employed by Assure subsidiaries concurrently monitor the useful integrity of sufferers’ neural constructions all through the process speaking in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to supply distinctive surgical care and a constructive affected person expertise. For extra data, go to the corporate’s web site at www.assureneuromonitoring.com.
Forward-Looking Statements
This information launch might include “forward-looking statements” throughout the which means of relevant securities legal guidelines, together with, however not restricted to feedback with respect to: the anticipated timing for mailing discover of the Annual Meeting to stockholders and the anticipated date for the Annual Meeting. Forward-looking statements might typically be recognized by means of the phrases “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” “target,” or “continue” and variations or related expressions. These statements are primarily based upon the present expectations and beliefs of administration and are topic to sure dangers and uncertainties that would trigger precise outcomes to vary materially from these described within the forward-looking statements. These dangers and uncertainties embrace, however will not be restricted to: the uncertainty surrounding the unfold of COVID-19 and the affect it is going to have on the Company’s operations and business, its distant neurology business, and financial exercise on the whole; and dangers and uncertainties mentioned in our most up-to-date annual and quarterly reviews filed with the United States Securities and Exchange Commission, together with our annual report on Form 10-Okay filed on March 14, 2022, and accessible on the Company’s EDGAR profile at www.sec.gov, which dangers and uncertainties are integrated herein by reference. Except as required by regulation, Assure doesn’t intend, and undertakes no obligation, to replace any forward-looking statements to replicate, specifically, new data or future occasions.
Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-617-2526
[email protected]